CliffBio
small molecule

METHYLPREDNISOLONE

METHYLPREDNISOLONE SODIUM SUCCINATE

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETHYLPREDNISOLONE
Active ingredientMETHYLPREDNISOLONE SODIUM SUCCINATE
StrengthEQ 500MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 1982
Marketing statusDISCN

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METHYLPREDNISOLONE patent cliff — loss of exclusivity — | CliffBio